Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens

Breast cancer therapies have made significant strides in improving survival for patients over the past decades. However, recurrence and drug resistance continue to challenge long-term recurrence-free and overall survival rates. Mounting evidence supports the cancer stem cell model in which the exist...

Full description

Bibliographic Details
Main Authors: Mai Nguyen, Clodia Osipo
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/12/6813
_version_ 1797486376569012224
author Mai Nguyen
Clodia Osipo
author_facet Mai Nguyen
Clodia Osipo
author_sort Mai Nguyen
collection DOAJ
description Breast cancer therapies have made significant strides in improving survival for patients over the past decades. However, recurrence and drug resistance continue to challenge long-term recurrence-free and overall survival rates. Mounting evidence supports the cancer stem cell model in which the existence of a small population of breast cancer stem cells (BCSCs) within the tumor enables these cells to evade conventional therapies and repopulate the tumor, giving rise to more aggressive, recurrent tumors. Thus, successful breast cancer therapy would need to target these BCSCs, as well the tumor bulk cells. Since the Women’s Health Initiative study reported an increased risk of breast cancer with the use of conventional hormone replacement therapy in postmenopausal women, many have turned their attention to phytoestrogens as a natural alternative. Phytoestrogens are plant compounds that share structural similarities with human estrogens and can bind to the estrogen receptors to alter the endocrine responses. Recent studies have found that phytoestrogens can also target BCSCs and have the potential to complement conventional therapy eradicating BCSCs. This review summarized the latest findings of different phytoestrogens and their effect on BCSCs, along with their mechanisms of action, including selective estrogen receptor binding and inhibition of molecular pathways used by BCSCs. The latest results of phytoestrogens in clinical trials are also discussed to further evaluate the use of phytoestrogen in the treatment and prevention of breast cancer.
first_indexed 2024-03-09T23:32:18Z
format Article
id doaj.art-93363951ebb647f398b434087e00be91
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:32:18Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-93363951ebb647f398b434087e00be912023-11-23T17:07:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-06-012312681310.3390/ijms23126813Targeting Breast Cancer Stem Cells Using Naturally Occurring PhytoestrogensMai Nguyen0Clodia Osipo1MD/PhD Program, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USABreast cancer therapies have made significant strides in improving survival for patients over the past decades. However, recurrence and drug resistance continue to challenge long-term recurrence-free and overall survival rates. Mounting evidence supports the cancer stem cell model in which the existence of a small population of breast cancer stem cells (BCSCs) within the tumor enables these cells to evade conventional therapies and repopulate the tumor, giving rise to more aggressive, recurrent tumors. Thus, successful breast cancer therapy would need to target these BCSCs, as well the tumor bulk cells. Since the Women’s Health Initiative study reported an increased risk of breast cancer with the use of conventional hormone replacement therapy in postmenopausal women, many have turned their attention to phytoestrogens as a natural alternative. Phytoestrogens are plant compounds that share structural similarities with human estrogens and can bind to the estrogen receptors to alter the endocrine responses. Recent studies have found that phytoestrogens can also target BCSCs and have the potential to complement conventional therapy eradicating BCSCs. This review summarized the latest findings of different phytoestrogens and their effect on BCSCs, along with their mechanisms of action, including selective estrogen receptor binding and inhibition of molecular pathways used by BCSCs. The latest results of phytoestrogens in clinical trials are also discussed to further evaluate the use of phytoestrogen in the treatment and prevention of breast cancer.https://www.mdpi.com/1422-0067/23/12/6813breast cancercancer stem cellsphytoestrogensgenisteinresveratrol
spellingShingle Mai Nguyen
Clodia Osipo
Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
International Journal of Molecular Sciences
breast cancer
cancer stem cells
phytoestrogens
genistein
resveratrol
title Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
title_full Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
title_fullStr Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
title_full_unstemmed Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
title_short Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
title_sort targeting breast cancer stem cells using naturally occurring phytoestrogens
topic breast cancer
cancer stem cells
phytoestrogens
genistein
resveratrol
url https://www.mdpi.com/1422-0067/23/12/6813
work_keys_str_mv AT mainguyen targetingbreastcancerstemcellsusingnaturallyoccurringphytoestrogens
AT clodiaosipo targetingbreastcancerstemcellsusingnaturallyoccurringphytoestrogens